Gerald R. Kovacs

859 total citations
17 papers, 702 citations indexed

About

Gerald R. Kovacs is a scholar working on Genetics, Molecular Biology and Epidemiology. According to data from OpenAlex, Gerald R. Kovacs has authored 17 papers receiving a total of 702 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Genetics, 6 papers in Molecular Biology and 6 papers in Epidemiology. Recurrent topics in Gerald R. Kovacs's work include Virus-based gene therapy research (7 papers), Viral Infectious Diseases and Gene Expression in Insects (6 papers) and Poxvirus research and outbreaks (5 papers). Gerald R. Kovacs is often cited by papers focused on Virus-based gene therapy research (7 papers), Viral Infectious Diseases and Gene Expression in Insects (6 papers) and Poxvirus research and outbreaks (5 papers). Gerald R. Kovacs collaborates with scholars based in United States and Somalia. Gerald R. Kovacs's co-authors include Linda A. Guarino, Bernard Moss, M D Summers, Max D. Summers, Donald L. Jarvis, Jo-Ann G. W. Fleming, Nikos Vasilakis, Jae‐Phil Choi, James Keck and Gretchen L. Eiben and has published in prestigious journals such as Nature Biotechnology, Clinical Infectious Diseases and Journal of Virology.

In The Last Decade

Gerald R. Kovacs

17 papers receiving 659 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gerald R. Kovacs United States	13	409	181	170	154	124	17	702
Mark Cochran United States	9	422 1.0×	260 1.4×	114 0.7×	191 1.2×	125 1.0×	17	740
Priya Raja United States	11	265 0.6×	81 0.4×	224 1.3×	55 0.4×	116 0.9×	12	974
Dina Alzhanova United States	11	114 0.3×	42 0.2×	98 0.6×	104 0.7×	129 1.0×	14	547
Elad Milrot Israel	12	346 0.8×	36 0.2×	240 1.4×	300 1.9×	39 0.3×	18	632
Christian Hertig Germany	13	188 0.5×	96 0.5×	149 0.9×	85 0.6×	17 0.1×	26	603
Nils Elias Lukacs Hungary	8	207 0.5×	45 0.2×	311 1.8×	27 0.2×	58 0.5×	13	672
J. D. Knell United States	11	309 0.8×	103 0.6×	144 0.8×	9 0.1×	164 1.3×	18	594
Gary L. Stiegler United States	11	262 0.6×	115 0.6×	76 0.4×	55 0.4×	23 0.2×	16	502
Teresa A. Galvin United States	9	106 0.3×	88 0.5×	116 0.7×	114 0.7×	15 0.1×	15	321
C.H. Hsu United States	13	191 0.5×	128 0.7×	188 1.1×	56 0.4×	18 0.1×	18	533

Countries citing papers authored by Gerald R. Kovacs

Since Specialization

Citations

This map shows the geographic impact of Gerald R. Kovacs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerald R. Kovacs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerald R. Kovacs more than expected).

Fields of papers citing papers by Gerald R. Kovacs

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerald R. Kovacs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerald R. Kovacs. The network helps show where Gerald R. Kovacs may publish in the future.

Co-authorship network of co-authors of Gerald R. Kovacs

This figure shows the co-authorship network connecting the top 25 collaborators of Gerald R. Kovacs. A scholar is included among the top collaborators of Gerald R. Kovacs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerald R. Kovacs. Gerald R. Kovacs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Hofmeyer, Kimberly A., Christy L. Ventura, Kimberly L. Armstrong, et al.. (2024). Project NextGen: Developing the Next Generation of COVID-19 Vaccines and Therapeutics to Respond to the Present and Prepare for the Future. Clinical Infectious Diseases. 79(1). 115–121. 6 indexed citations

Wolfe, Daniel, Gloria L. David, Lakshmi Jayashankar, et al.. (2024). Development of Next-Generation COVID-19 Vaccines: Biomedical Advanced Research and Development Authority (BARDA)–Supported Phase 2b Study Designs. Clinical Infectious Diseases. 79(4). 928–935. 2 indexed citations

Grace, Marcy B., Brian R. Moyer, C. Norman Coleman, et al.. (2011). THE U.S. GOVERNMENT'S MEDICAL COUNTERMEASURE PORTFOLIO MANAGEMENT FOR NUCLEAR AND RADIOLOGICAL EMERGENCIES: SYNERGY FROM INTERAGENCY COOPERATION. Health Physics. 101(3). 238–247. 9 indexed citations

Kovacs, Gerald R., Christopher L. Parks, Nikos Vasilakis, & Stephen A. Udem. (2003). Enhanced genetic rescue of negative-strand RNA viruses: use of an MVA-T7 RNA polymerase vector and DNA replication inhibitors. Journal of Virological Methods. 111(1). 29–36. 25 indexed citations

Kovacs, Gerald R., et al.. (2003). A method of alphavirus replicon particle titration based on expression of functional replicase/transcriptase. Journal of Virological Methods. 109(2). 133–138. 3 indexed citations

Vasilakis, Nikos, John W. Coleman, Jacek Kowalski, et al.. (2003). Transfection-independent production of alphavirus replicon particles based on poxvirus expression vectors. Nature Biotechnology. 21(8). 932–935. 12 indexed citations

Parks, Christopher L., Gerald R. Kovacs, Nikos Vasilakis, et al.. (2002). Expression of a foreign gene by recombinant canine distemper virus recovered from cloned DNAs. Virus Research. 83(1-2). 131–147. 21 indexed citations

Velders, Markwin P., M. Cristina Cassetti, Gretchen L. Eiben, et al.. (2001). Eradication of established tumors by vaccination with Venezuelan equine encephalitis virus replicon particles delivering human papillomavirus 16 E7 RNA.. PubMed. 61(21). 7861–7. 113 indexed citations

Kovacs, Gerald R., Nikos Vasilakis, & Bernard Moss. (2001). Regulation of Viral Intermediate Gene Expression by the Vaccinia Virus B1 Protein Kinase. Journal of Virology. 75(9). 4048–4055. 24 indexed citations

10.

Passarelli, A. Lorena, Gerald R. Kovacs, & Bernard Moss. (1996). Transcription of a vaccinia virus late promoter template: requirement for the product of the A2L intermediate-stage gene. Journal of Virology. 70(7). 4444–4450. 14 indexed citations

11.

Kovacs, Gerald R. & Bernard Moss. (1996). The vaccinia virus H5R gene encodes late gene transcription factor 4: purification, cloning, and overexpression. Journal of Virology. 70(10). 6796–6802. 71 indexed citations

12.

Kovacs, Gerald R., Ricardo Rosales, James Keck, & Bernard Moss. (1994). Modification of the cascade model for regulation of vaccinia virus gene expression: purification of a prereplicative, late-stage-specific transcription factor. Journal of Virology. 68(5). 3443–3447. 16 indexed citations

13.

Keck, James, Gerald R. Kovacs, & Bernard Moss. (1993). Overexpression, purification, and late transcription factor activity of the 17-kilodalton protein encoded by the vaccinia virus A1L gene. Journal of Virology. 67(10). 5740–5748. 32 indexed citations

14.

Kovacs, Gerald R., Jae‐Phil Choi, Linda A. Guarino, & M D Summers. (1992). Functional dissection of the Autographa californica nuclear polyhedrosis virus immediate-early 1 transcriptional regulatory protein. Journal of Virology. 66(12). 7429–7437. 70 indexed citations

15.

Kovacs, Gerald R., Linda A. Guarino, & M D Summers. (1991). Novel regulatory properties of the IE1 and IE0 transactivators encoded by the baculovirus Autographa californica multicapsid nuclear polyhedrosis virus. Journal of Virology. 65(10). 5281–5288. 93 indexed citations

16.

Kovacs, Gerald R., Linda A. Guarino, Brent Graham, & Max D. Summers. (1991). Identification of spliced baculovirus RNAs expressed late in infection. Virology. 185(2). 633–643. 41 indexed citations

17.

Jarvis, Donald L., Jo-Ann G. W. Fleming, Gerald R. Kovacs, Max D. Summers, & Linda A. Guarino. (1990). Use of Early Baculovirus Promoters for Continuous Expression and Efficient Processing of Foreign Gene Products in Stably Transformed Lepidopteran Cells. Nature Biotechnology. 8(10). 950–955. 150 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact